A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis
about
Perspectives on menopause and women with HIVHIV infection and osteoporosisHIV infection and bone disease.Aging, human immunodeficiency virus, and bone health.Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenzZoledronic acid: clinical utility and patient considerations in osteoporosis and low bone massTargeting γδ T cells for immunotherapy of HIV diseaseBone disease in HIV infection: a practical review and recommendations for HIV care providers.Recommendations for evaluation and management of bone disease in HIV.Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients.Bone disease in HIV infection.Osteopenia and osteoporosis in people living with HIV: multiprofessional approachRole of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss.Care of the human immunodeficiency virus-infected menopausal woman.HIV and its effects on bone: a primer for rheumatologistsHIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture.Adverse bone health among children and adolescents growing up with HIV.Therapeutic options for low bone mineral density in HIV-infected subjects.Osteoporosis and bone health in HIV.Osteoporosis in young adults: pathophysiology, diagnosis, and management.HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.Bone health and human immunodeficiency virus infection.Bone and vitamin D metabolism in HIV.Management of bone mineral density in HIV-infected patients.HIV and Bone Complications: Understudied Populations and New Management Strategies.Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years.Bone alterations associated with HIV.Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks.Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection.Continued Interest and Controversy: Vitamin D in HIV.The Hidden Burden of Fractures in People Living With HIV
P2860
Q26772852-474A2FF5-6030-4550-BCF9-289078EEA499Q26853139-96C068CF-301F-4EA8-A78E-246AFC05F464Q30249771-63903106-D93F-4E46-B17E-FDAA858EFF1CQ34160511-0B2BCEDD-3816-455A-8FFC-D5D6EE7035F4Q34248604-CE8A8E49-763E-4215-83E3-4198B20871D7Q34389524-46E93AC7-D4BD-4558-AEE4-B19D26440D16Q34585223-A8853466-216C-48F7-938C-0E6286C7356BQ35019051-6735115A-E268-4032-8EF9-EE56A3DF34E7Q35451868-9016376D-C672-41F4-873B-644312FE228AQ35578707-92EE9CC7-0F87-44D9-8720-4A9DD5FFBC21Q35593296-27D3B7F2-64A8-47B8-BE3B-EE55F24E2F30Q35671760-47247C87-9FF8-4063-830C-5A3C1247EAE0Q36087907-A99DCC26-6CD5-44FF-A0C9-78203661099BQ36128333-6ABFFC3A-3A1D-49D4-AC57-5F88D254D60DQ36381079-5E035F22-04FF-439D-8B7E-8F32F621E010Q36783435-F13452C7-013B-4B60-A390-1BFFBC916CEDQ37098360-600C4242-7BAD-4101-9774-426C2FAB6FFBQ38005045-0F1C340A-C48A-48F2-B18C-E743E01E7959Q38009732-A3A5FF98-89F4-4FB2-9737-6731271F89E8Q38017609-053210F2-58B8-4AB1-A699-4F2C058B00FFQ38055705-97648671-5DFF-4079-9944-AC154FDA151DQ38095828-F6DF643C-CE8B-4D6F-BE9D-5D2F5611E2DEQ38105268-A917B1FD-6C1B-44D9-A3CB-60ABE10D7F63Q38711437-A0D9EED4-850D-4A86-8CEA-39E0AE0EEEA3Q38978479-7D8330E7-E7D3-4B87-BD47-6428BC72C71DQ39010553-6459DFFF-97EB-47AB-975F-977E2B03A773Q42203594-67C54B10-53CD-407C-A32F-5EDF35560F44Q42241391-A375A606-E80E-4EA1-940A-3597B190F964Q45363289-212032F9-19B0-40A6-B942-A2552921D939Q54224147-03BDC0FB-5A01-4C99-AF5D-CDF09C3E03DDQ57143538-75EABCC2-F7EB-4A1C-A87E-86D7B1FD9C3E
P2860
A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A double-blinded, randomized c ...... ed osteopenia and osteoporosis
@ast
A double-blinded, randomized c ...... ed osteopenia and osteoporosis
@en
type
label
A double-blinded, randomized c ...... ed osteopenia and osteoporosis
@ast
A double-blinded, randomized c ...... ed osteopenia and osteoporosis
@en
prefLabel
A double-blinded, randomized c ...... ed osteopenia and osteoporosis
@ast
A double-blinded, randomized c ...... ed osteopenia and osteoporosis
@en
P2093
P2860
P1433
P1476
A double-blinded, randomized c ...... ed osteopenia and osteoporosis
@en
P2093
J Allen McCutchan
Linda Meixner
Susan Fernandez
P2860
P356
10.1097/QAD.0B013E32831C8ADC
P407
P577
2009-01-01T00:00:00Z